Together we will beat cancer

Donate

Proposed cuts to Europe’s research budget – why we’re fighting back

We explain why a set of proposed cuts to the European research budget could be bad news for the UK research scene.

Read More

Election 2015: What does the result mean for cancer?

As the dust settles on an unexpected election result, we look at what the UK’s new political landscape means for political action against cancer.

Read More

What have we done to Cross Cancer Out ahead of the General Election?

We look back on our General Election campaign, covering all the different ways we’ve been asking election candidates to help Cross Cancer Out.

Read More

Election 2015: what are the parties from Scotland, Wales and Northern Ireland saying about cancer?

We’ve been looking at the party manifestos from the devolved nations – here’s what’s being said about cancer, health and research.

Read More

Election 2015: what are the parties saying about cancer?

We open up the various political party manifestos and see what they are saying about cancer and research.

Read More

How the NHS could improve cancer survival over the next five years

Last Friday was the deadline to submit evidence to NHS England’s Cancer Taskforce – and we, like many others, put in a response. Read what it included.

Read More

My role as independent chair of the Cancer Strategy Taskforce

Our chief executive, Harpal Kumar, has been invited to be the independent chair of a new Cancer Strategy Taskforce – here he explains what that will involve.

Read More

Our highlights from 2014

We look back over 2014 and pick out a selection of highlights from our groundbreaking research and policy and campaigning work.

Read More

“I want to make sure that radiotherapy is accessible to everyone” – Elizabeth’s story

Cancer Campaigns Ambassador Elizabeth Bailey shares her personal story of breast cancer and why she campaigns for Government to improve access to radiotherapy.

Read More

A welcome review of how treatments get to patients

The UK Government has announced it will review the process for getting new cancer treatments to patients more quickly – so what happens next?

Read More